About
Emma Valentine is an Equity Research Analyst at Frontier Capital Management Co. LLC in Boston, Massachusetts, where she has served since 2023. In her role, she conducts in-depth fundamental research and analysis to support investment decisions across the company’s actively managed equity portfolios, with a focus on growth and value strategies for institutional clients. Her work specifically emphasizes the biotechnology sector, leveraging her specialized knowledge to identify high-potential companies and trends within this dynamic field.
Prior to joining Frontier Capital Management, Ms. Valentine gained experience in both the financial and banking sectors, including serving as a Universal Banker at Horizon Bank. Her academic background includes an undergraduate degree from the Massachusetts Institute of Technology (MIT) and an MBA from Harvard Business School, completed in 2023.
Emma Valentine is recognized for her rigorous analytical approach and sector expertise in biotechnology, providing valuable insights that influence Frontier’s investment strategies. Her combined scientific and financial skillset, along with her educational credentials from top-tier institutions, have positioned her as a key contributor to the research and execution of specialized equity portfolios within the healthcare and biotech space.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Frontier Capital Management Co | Biotech Analyst | Sep 2023 to Present | — |
| Novo Ventures | Summer Associate | May 2022 to Aug 2022 | — |
| Accenture Strategy | Strategy Consultant | Dec 2019 to Jul 2021 | — |
| Accenture Strategy | Senior Strategy Analyst | Dec 2018 to Dec 2019 | — |
| Accenture Strategy | Strategy Analyst | Aug 2017 to Dec 2018 | — |
| Navigant Consulting, Inc. | Summer Associate | May 2016 to Aug 2016 | Researched and interviewed external experts, such as top clinical doctors and researchers, on existing and future treatment paradigms for diseases such as multiple myeloma, schizophrenia, acute heart ... |
| Pioneer Natural Resources | Engineering Intern | May 2015 to Aug 2015 | Investigated advanced technology opportunity areas for energy. Collaborated with vendors and national research institutes to present technology prototypes to department VP. Created and implemented aut... |
| MIT - Undergraduate Researcher | Prather Lab - Undergraduate Researcher | Jun 2014 to May 2015 | Testing new dual selective markers in E. Coli in order to alter metabolic pathways in different strains of E. Coli. Performs PCR, Gel Electrophoresis, genetic transformations of plasmids and oligonucl... |
| Griffith and Hammond Labs | Griffith and Hammond Labs - Undergraduate Researcher | Jan 2014 to Jun 2014 | Created 3D synthetic micro-environments for human liver and pancreatic beta cells to grow on. The liver and pancreatic tissue was later used in a microfluidic platform connecting engineered tissue fr... |
Education
Harvard Business School
Master of Business Administration (MBA) and Masters of Biotechnology
2021 — 2023
Massachusetts Institute of Technology
Bachelor's Degree, Chemical Biological Engineering
2013 — 2017
Maine-Endwell Senior High School
High School
2009 — 2013
Others at Frontier Capital Management Co. LLC (18)
| Name | Role | Location |
|---|---|---|
D Drew Bennett | Vice President | Hingham, MA , United States |
 | Research Analyst | Cambridge, MA , United States |
 | Partner, Vice-President | Boston, MA , United States |
 | Vice President | Needham, MA , United States |
J Jason Wolff | President | Wilson, WY , United States |
 | Research Analyst | Cambridge, MA , United States |
 | Portfolio Manager | Boston, MA , United States |
N Nathan Hayman | Portfolio Manager | Lebanon, NH , United States |
 | Vice President | Lexington, MA , United States |
S Sarah Jankowski | Co-Managing Partner and Chief Operating Officer | Boston, MA , United States |